Predictors of long-term risk for heart failure hospitalization after acute myocardial infarction

Annals of Noninvasive Electrocardiology

Volumn 15, Issue 3, 2010, Pages 250-258

  Perkiömäki, Juha S ^a   Hämekoski, Sari ^a   Junttila, M Juhani ^a   Jokinen, Vesa ^a   Tapanainen, Jari ^a   Huikuri, Heikki V ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

baroreflex sensitivity; brain natriuretic peptide; heart failure; heart rate turbulence; heart rate variability; myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHENYLEPHRINE; WARFARIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART RATE VARIABILITY; HOLTER MONITORING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ACUTE DISEASE; AGED; BAROREFLEX; BIOLOGICAL MARKERS; CAUSALITY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE;

EID: 77954626813     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2010.00372.x     Document Type: Article

References (31)

1. Lewis EF, Moye LA, Rouleau JL, et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: The CARE study. J Am Coll Cardiol 2003 42 : 1446 1453.
2. Herlitz J, Waagstein F, Lindqvist J, et al. Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Goteborg Metoprolol Trial). Am J Cardiol 1997 80 : 40J 44J.
3. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999 353 : 9 13.
4. Pfeffer MA, Swedberg K, Granger CB, et al CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-overall programme. Lancet 2003 362 : 759 766. (Pubitemid 37093915)
5. Cleland JG, Daubert JC, Erdmann E, et al Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352 : 1539 1549.
6. Yerra L, Anavekar N, Skali H, et al. Association of QRS duration and outcomes after myocardial infarction: The VALIANT trial. Heart Rhythm 2006 3 : 313 316.
7. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004 351 : 1285 1295.
8. Huikuri HV, Tapanainen JM, Lindgren K, et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003 42 : 652 658.
9. Tapanainen JM, Still AM, Airaksinen KEJ, et al. Prognostic significance of risk stratifiers of mortality, including T wave alternans, after acute myocardial infarction: Results of a prospective follow-up study. J Cardiovasc Electrophysiol 2001 12 : 645 652.
10. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 470.
11. Iyengar N, Peng CK, Morin R, et al. Age-related alterations in the fractal scaling of cardiac interbeat interval dynamics. Am J Physiol 1996 271 : R1078 R1084.
12. Peng CK, Havlin S, Stanley HE, et al. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. CHAOS 1995 1 : 82 87.
13. Huikuri HV, Makikallio TH, Peng CK, et al. Fractal correlation properties of R-R interval dynamic mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 2000 101 : 47 53.
14. Schmidt G, Malik M, Barthel P, et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 1999 353 : 1390 1396.
15. Barthel P, Schneider R, Bauer A, et al. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation 2003 108 : 1221 1226.
16. Airaksinen KE, Tahvanainen KU, Eckberg DL, et al. Arterial baroreflex impairment in patients during acute coronary occlusion. J Am Coll Cardiol 1998 32 : 1641 1647.
17. Wang CS, FitzGerald JM, Schulzer M, et al. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA 2005 294 : 1944 1956.
18. Wright SP, Doughty RN, Pearl A, et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: A randomized, controlled trial. J Am Coll Cardiol 2003 42 : 1793 1800.
19. Latour-Perez J, Coves-Orts FJ, Abad-Terrado C, et al. Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: A systematic review. Eur J Heart Fail 2006 8 : 390 399.
20. Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000 355 : 1126 1130.
21. Weinfeld MS, Chertow GM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999 138 : 285 290.
22. Hunt SA American College of Cardiology; American Heart Association Task Force on Practice Guidelines. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005 46 : e1 e82.
23. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004 350 : 647 654. (Pubitemid 38364623)
24. Kleiger RE, Miller JP, Bigger JT Jr., et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987 59 : 256 262.
25. Bigger JT Jr., Fleiss JL, Steinman RC, et al. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992 85 : 164 171.
26. Huikuri HV, Makikallio T, Airaksinen KE, et al. Measurement of heart rate variability: A clinical tool or a research toy? J Am Coll Cardiol 1999 34 : 1878 1883.
27. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998 98 : 1510 1516.
28. Mäkikallio TH, Barthel P, Schneider R, et al. Prediction of sudden cardiac death after acute myocardial infarction: Role of Holter monitoring in the modern treatment era. Eur Heart J 2005 26 : 762 769.
29. Makikallio TH, Huikuri HV, Hintze U, et al DIAMOND Study Group (Danish Investigations of Arrhythmia and Mortality ON Dofetilide). Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol 2001 87 : 178 182.
30. Tsuji H, Larson MG, Venditti FJ Jr., et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996 94 : 2850 2855.
31. La Rovere MT, Bigger JT Jr., Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic tone and reflexes after myocardial infarction)investigators. Lancet 1998 351 : 478 484.